Lemonex

Lemonex, as a global research-oriented pharmaceutical company, is developing innovative next-generation drug delivery technologies and biosensor technologies. Based on these, the company is developing immuno-oncology drugs and gene therapies. DegradaBALL® is a modular next-generation drug delivery technology and Lemonex's proprietary technology. This technology enables in vivo delivery by loading various new drug candidates within particles and has been optimized for the development of gene therapies and immuno-oncology drugs. Lemonex is leveraging the DegradaBALL® drug delivery platform to develop siRNA gene therapy, mRNA vaccines, and dual-action RNA (dual-action RNA) immunotherapy. The company is also developing a drug delivery platform technology focused on the rapid development and supply of infectious disease vaccines.